Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo García-Pavía

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Practice|January 19, 2017
Time delays in the diagnosis and treatment of Fabry diseaseRicardo Reisin, Amandine Perrin, Pablo García-Pavía
European Heart Journal|June 7, 2024
Alcoholic cardiomyopathy: an updateFernando Domínguez, Eric Adler, Pablo García-Pavía
Revista Espanola De Cardiologia|December 6, 2006
[Cardiac resynchronization therapy and prevention of sudden cardiac death in heart failure. From clinical trials to clinical practice]Lorenzo Silva Melchor, Pablo García-Pavía, Javier Ortigosa Aso
Revista Espanola De Cardiologia|July 22, 2011
[Amyloidosis. Also a heart disease]Pablo García-Pavía, María Teresa Tomé-Esteban, Claudio Rapezzi
Journal of Cardiovascular Translational Research|June 19, 2013
The alternative heart: impact of alternative splicing in heart diseaseEnrique Lara-Pezzi, Jesús Gómez-Salinero, Alberto Gatto, et al.
Journal of Cardiovascular Translational Research|August 17, 2017
Systolic Dysfunction in Infarcted Mice Does Not Necessarily Lead to Heart Failure: Need to Refine Preclinical ModelsMaría Villalba-Orero, Marina López-Olañeta, Pablo García-Pavía, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 18, 2025
Cost analysis of transthyretin amyloid cardiomyopathy in heart failure patients with preserved ejection fraction in SpainPablo García-Pavía, José Manuel García-Pinilla, Javier Rejas-Gutierrez, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 27, 2021
A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosisThibaud Damy, Isabel Conceição, Pablo García-Pavía, et al.
European Heart Journal. Case Reports|March 13, 2024
Pathogenic truncating filamin C mutations presenting as acute myocarditis: a case series with insights from cardiac magnetic resonance and histological analysisApostolos Vrettos, Polyvios Demetriades, Martín Ortiz, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Practice|January 19, 2017
Time delays in the diagnosis and treatment of Fabry diseaseRicardo Reisin, Amandine Perrin, Pablo García-Pavía
European Heart Journal|June 7, 2024
Alcoholic cardiomyopathy: an updateFernando Domínguez, Eric Adler, Pablo García-Pavía
Revista Espanola De Cardiologia|December 6, 2006
[Cardiac resynchronization therapy and prevention of sudden cardiac death in heart failure. From clinical trials to clinical practice]Lorenzo Silva Melchor, Pablo García-Pavía, Javier Ortigosa Aso
Revista Espanola De Cardiologia|July 22, 2011
[Amyloidosis. Also a heart disease]Pablo García-Pavía, María Teresa Tomé-Esteban, Claudio Rapezzi
Journal of Cardiovascular Translational Research|June 19, 2013
The alternative heart: impact of alternative splicing in heart diseaseEnrique Lara-Pezzi, Jesús Gómez-Salinero, Alberto Gatto, et al.
Journal of Cardiovascular Translational Research|August 17, 2017
Systolic Dysfunction in Infarcted Mice Does Not Necessarily Lead to Heart Failure: Need to Refine Preclinical ModelsMaría Villalba-Orero, Marina López-Olañeta, Pablo García-Pavía, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 18, 2025
Cost analysis of transthyretin amyloid cardiomyopathy in heart failure patients with preserved ejection fraction in SpainPablo García-Pavía, José Manuel García-Pinilla, Javier Rejas-Gutierrez, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 27, 2021
A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosisThibaud Damy, Isabel Conceição, Pablo García-Pavía, et al.
European Heart Journal. Case Reports|March 13, 2024
Pathogenic truncating filamin C mutations presenting as acute myocarditis: a case series with insights from cardiac magnetic resonance and histological analysisApostolos Vrettos, Polyvios Demetriades, Martín Ortiz, et al.
Pageof 10